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Salivary gland biopsy is a technique broadly applied for the diagnosis of Sjögren’s 
syndrome (SS), lymphoma accompanying SS, sarcoidosis, amyloidosis and other 
connective tissue disorders. SS has characteristic microscopic findings, involving 
lymphocytic infiltration surrounding the excretory ducts in combination with de-
struction of acinar tissue (Figure 1). In affected parotid glands, epimyoepithelial 
islands in a background of lymphoid stroma can be additionally seen and lympho-
epithelial lesions (LELs) are a common phenomenon (Figure 2). 
Biopsy of the labial salivary glands is considered as one of the four objective Eu-
ropean- American Consensus Group classification criteria (AECG) and one of the 
three objective American College of Rheumatology (ACR) classification criteria for 
SS (Table 1). While the parotid biopsy has been shown as an alternative for labial 
salivary gland biopsy when applying AECG classification criteria, it has still to be 
validated in regard to the ACR classification criteria [1].
This chapter will focus on the main techniques used for taking labial and parotid 
salivary gland biopsies in the diagnostic work-up of SS with respect to their ad-
vantages, their post-operative complications, and their usefulness for diagnostic 
procedures, monitoring disease progression and treatment evaluation. 
Figure 1: Lymphocytic infiltration (*) sur-
rounding excretory ducts and destruction of 
acini. 
Figure 2: Lymphoepithelial lesions (*) form 
as the result of atrophy of the columnar 
ductal epithelium and proliferation of basal 
epithelial cells, associated with intraepithe-
lial infiltration.
Key Points 
•	 Lymphocytic sialadenitis in labial salivary glands is a widely accepted criterion 
for histological confirmation of Sjögren’s syndrome (SS).
•	 Sensitivity and specificity of parotid and labial biopsies for diagnosing SS are 
comparable. 
•	 Parotid gland incision biopsy can overcome most of the disadvantages of la-
bial gland excision biopsy.
•	 In contrast to labial salivary glands, lymphoepithelial lesions and early stage 
lymphomas can be often observed in parotid gland tissue of SS patients.
•	 Parotid tissue can be harvested easily, repeated biopsies from the same pa-
rotid gland are possible, and histopathological results can be compared with 
other diagnostic results derived from the same gland.
•	 Parotid biopsies, in contrast to labial salivary gland biopsies, allow the clinician 
to prospectively monitor disease progression and to assess effects of interven-








just behind the wet line through the mucosa and submucosa [11]. An oblique inci-
sion, starting 1.5 cm from the midline and proceeding latero-inferiorly, avoiding 
the glandular free zone in the center of the lower lip was advocated by Berquin 
and colleagues [12]. Caporali et al. reported a small incision of 2-3 mm on the inner 
surface of the lower lip [13]. In view of the lack of sufficient evidence to support 
the superiority of one technique over the others, especially in respect to short 
and long term morbidity, the shape and the size of the incision can be considered 
a matter of preference. Incision shape has included elliptical, horizontal, vertical 
and wedge shapes, and incision length has varied from a few mm to 2 cm. The 
authors of the present article, based on their clinical experience, suggest a hori-
zontal incision of approximately 2 cm in agreement with the technique proposed 
by Greenspan and colleagues [6], where the surgeon uses loupe operation glasses 
(magnification x2.5) to precisely excise the salivary glands without disturbing the 
direct underlying sensible nerves (Figure 4).
The first grading system for salivary gland biopsies was employed by Chisholm 
and Mason in an attempt to standardize the examined area and record the degree 
of histopathological change [5]. At present, according to the revised AECG clas-
sification criteria and the ACR classification criteria for SS, a labial salivary gland 
biopsy is considered positive if minor salivary glands (obtained through normal 
appearing mucosa) demonstrate focal lymphocytic sialadenitis, evaluated by an 
expert histopathologist, with a focus score ≥1, defined as a number of lymphocytic 
foci, containing more than 50 lymphocytes per 4 mm2 of glandular tissue (Table 1). 
Complications
The most commonly reported complications of labial gland biopsy are [1,6-8,10,12-
17]:
1. Localized sensory alteration, which is frequently described with the terms an-
esthesia, reduced or partial loss of sensation, transitory numbness and hypo-
esthesia. The condition may last for a few months or can be even permanent;
2. External haematoma;
3. Local swelling;
4. Formation of granulomas;
5. Internal scarring and cheloid formation;
6. Failing sutures;
7. Local pain. 
Suitability for diagnostic and treatment evaluation purposes
A widely accepted criterion for histological confirmation of SS is focal lymphocytic 
sialadenitis in labial salivary glands [18,19]. Labial biopsies are mainly well suited for 
the diagnostic work-up, but not for treatment and disease activity evaluation [20], 
Labial salivary gland biopsy
Minor salivary glands are widely distributed in the labial, buccal and palatal muco-
sa of the oral cavity [2]. Since pathognomonic changes are seen in minor salivary 
glands, the minor salivary gland biopsy is largely used for assisting the diagnosis 
of SS. Labial salivary glands in particular are easily accessible, lie above the muscle 
layer and are separated from the oral mucous membrane by a thin layer of fibrous 
connective tissue. Although the chance of excessive bleeding is minimal, since the 
arterial supply to the lip lies deep [3], there is a risk of sensible nerve injury, as the 
branches of the mental nerve in the lower lip are closely associated to the minor 
salivary glands (Figure 3) [4]. 
Labial salivary gland biopsies in the diagnosis of SS was introduced by Chisholm 
and Mason in 1968 and involved oral preparation of the patient with local anes-
thetic infiltration followed by excising an ellipse of oral mucous membrane down 
to the muscle layer [5]. The wound was closed with 4-0 gauge silk sutures, which 
were removed after 4-5 days. Ideally 6 to 8 minor glands must be harvested and 
sent for histopathologic examination.
Several clinicians have revised this technique (Table 2). Greenspan and colleagues 
described a 1.5-2 cm linear incision of mucosa, parallel to the vermillion border 
and lateral to the midline [6]. Marx et al. modified Greenspan’s technique with a 
mucosal excision of 3x0.75 cm [7]. Delgado and Moscueda preferred a longitudinal 
incision of 1 cm in the labial mucosa in front of the mandibular cuspids [8]. Gue-
vara-Gutierrez and coworkers proposed the punch biopsy technique, performed 
with a 4 mm punch just penetrating the epithelium of the lower lip [9]. Mahlsted 
et al. re commended a 1-1.5 cm wedge-shaped excision of mucosa between the 
midline and commissure [10]. Gorson and Ropper reported a 1 cm vertical incision 
Table 1: Histological criteria for diagnosing SS on salivary gland biopsies [1,18,19].
Type of biopsy Positivity 
Labial gland if minor salivary glands (obtained through normal appearing mucosa) 
demonstrate focal lymphocytic sialadenitis, evaluated by an expert histo-
pathologist, with a focus score ≥1, defined as a number of lymphocytic foci 
(which are adjacent to normal appearing mucous acini and contain more 
than 50 lymphocytes) per 4 mm2 of glandular tissue
Parotid gland if one of the two following criteria is fulfilled: 
i. a focus score of ≥1, defined as the number of lymphocytic foci (which 
are adjacent to normal-appearing acini and contain >50 lymphocytes) 
per 4 mm2 of glandular parotid tissue (including fat tissue), irrespective 
of the presence of benign LELs
ii. small lymphocytic infiltrates, not fulfilling the criterion of a focus 








although very rare, B-cell MALT lymphomas can be found in labial biopsies of SS 
patients [21,22].
Parotid gland biopsy
The parotid gland is the largest salivary gland and is positioned on the lateral aspect 
of the face overlying the posterior surface of the mandible and antero-inferiorly to 
the auricle [23]. Traditionally, the gland is divided into a superficial and deep lobe 
based on the course of the facial nerve as it passes through. When the facial nerve 
enters the parotid gland, it forms a characteristic branching pattern that resembles 
a goose foot and is known as ‘the pes anserinus’, giving two main divisions of the 
facial nerve (Figure 5). Surgically, the facial nerve can be located in approximately 
2-4 mm deep to the inferior end of the tympanomastoid suture line and 1 cm deep 
and slightly antero-inferior to the tragal pointer. 
The technique of the parotid gland biopsy was initially described by Kraaijenhagen 
[24]: the area is anesthetized with local infiltration anesthesia after the standard 
preparation. With a No 15 blade, a small 1-2 cm incision is made just below the 
earlobe near the posterior angle of the mandible. The skin is incised and the pa-
Figure 5: The facial nerve enters the parotid gland forming a characteristic branching pattern 
that resembles a goose foot and is known as the pes anserinus, giving two main divisions of the 
facial nerve. The parotid gland is divided into a superficial and deep lobe based on the course of 
the facial nerve as it passes through. In the area of the incisional biopsy of the parotid gland, the 
distance between the gland surface and the facial nerve is approximately 1.5 cm.
Figure 3: The branch of the mental nerve (*) that supplies the mucous membrane of the lower lip 
divides usually into two sub-branches: a horizontal and a vertical, which has an ascending course 
toward the vermillion border and is in close relation to the labial salivary glands (**).
Figure 4: Harvesting labial salivary glands.
A. Horizontal incision of approximately 1.5 cm. 
C. Closure of the wound with 5-0 Vicryl 
rapide® (resorbable) inverted buried notch 
sutures. 








cosa. There are a few reports about taking a biopsy of the sublingual salivary gland 
for the diagnosis of SS [12,27,28]. The technique is performed with an 1 cm linear 
mucosal incision in the floor of the mouth, 1 cm anterolaterally from Wharton’s 
duct to 1 cm antero-posteriorly [12,28,28]. 
Complications
The post-operative complications of sublingual salivary gland biopsy are [12,27]:
1. Ligaturing Wharton’s duct, resulting from the placement of sutures;
2. Bleeding;
3. Swelling in the floor of the mouth.
Comparison of techniques (Table 2)
Although focal lymphocytic sialadenitis in the labial salivary gland is a widely ac-
cepted criterion for histological confirmation of SS, biopsies of the labial salivary 
glands may have several disadvantages. The sensitivity and specificity of labial 
salivary gland biopsies vary in the literature. Data from different studies are often 
difficult to compare because different sets of criteria for diagnosing SS have been 
used and the outcome of the labial biopsy is a strong determinant for the final 
diagnosis. In a normal population, the labial biopsy resulted in 6–9% false-positive 
diagnoses, and 18–40% of the patients with a clinical diagnosis of SS have a nega-
tive labial biopsy, resulting in a sensitivity of 60–82% and a specificity of 91–94% 
(Table 3) [14,29-33]. According to the ACR classification criteria, the labial biopsy 
has a sensitivity of 89.8 (95% CI: 87.2–92.0), but a lower specificity of 74.3 (95% 
CI: 71.0–77.5) [19]. Moreover, it may be difficult to harvest a sufficient number of 
labial salivary glands in atrophic submucosa of patients with longstanding SS [30]. 
In addition, permanent sensory loss of the mucosa of the lower lip, occurring in 
1–10% of the patients, is a known complication of a labial biopsy [7,14,15]. Pijpe and 
coworkers report sensory loss in 6% of patients after labial biopsy, while no perma-
nent sensory loss was observed after parotid biopsy [1].
Incisional biopsy of the parotid gland can overcome most of the disadvantages 
of the labial biopsy. When evaluating the parotid and the labial biopsy, sensitivity 
and specificity are comparable (Table 3), estimated in 78% and 86% respectively 
[1]. Parotid gland tissue can be harvested easily, repeated biopsies from the same 
parotid gland are possible (an important asset in studies assessing the efficacy of 
a treatment in SS patients or monitoring disease progression), and the histopatho-
logical results can be compared with other diagnostic results derived from the 
same gland (secretory function, sialographic appearance, ultrasound). In contrast 
to labial salivary glands, LELs are often observed in parotid gland tissue of SS pa-
tients. These LELs, a characteristic histological feature of the major salivary glands 
rotid capsule is exposed by blunt dissection. The capsule of the gland is carefully 
opened and a small amount of superficial parotid tissue is removed. The procedure 
is completed with a 2 to 3-layered closure. The capsule must be cautiously closed 
to avoid future leakage or development of sialocele (Figure 6). 
The technique was slightly modified by the present authors with an incision below 
and slightly behind the earlobe (Figure 7). The capsule of the parotid gland and 
subcutaneous tissue is closed with 4-0 Vicryl® sutures, whereas the skin is closed 
with 5-0 Ethilon® sutures. In this way, aesthetic results are excellent and future scar 
is invisible to the eye from anterior/lateral point of view. 
Pijpe and coworkers established a new set of validated histopathological criteria 
for diagnosing SS according to the AECG classification criteria based on biopsy of 
the parotid gland (Table 1) [1]. A parotid biopsy was considered positive if one of 
the two following criteria was fulfilled: 
i. a focus score of ≥1, defined as the number of lymphocytic foci (which are ad-
jacent to normal-appearing acini and contain >50 lymphocytes) per 4  mm2 of 
glandular parotid tissue (including fat tissue), irrespective of the presence of 
benign LELs.
ii. small lymphocytic infiltrates, not fulfilling the criterion of a focus score of ≥1, in 
combination with the presence of benign LELs. 
Complications
Despite the potential risk of facial nerve damage, the development of sialoceles 
and salivary fistulae, temporary change in sensation in the skin area of the incision 
is the only well documented complication described to date [1,7]. 
Suitability for diagnostic and treatment evaluation purposes
Parotid biopsies allow the clinician to monitor disease progression and to assess 
the effect of an intervention treatment in SS. This is feasible due to the fact that pa-
rotid tissue can be harvested easily, repeated biopsies from the same parotid gland 
are possible, and the histopathological results can be compared with other diag-
nostic results derived from the same gland (e.g. secretory function, sialographic 
appearance, and ultrasound) [25]. Additionally, by performing parotid biopsies as 
a routine diagnostic procedure for SS, LELs and lymphomas located in the parotid 
gland can be identified [7,26].
Sublingual salivary gland biopsy
The sublingual salivary gland is the smallest of the major salivary glands. It lies in 








for the management of MALT-type lymphoma of parotid gland and associated SS 
(MALT-SS), showing the importance of a parotid gland biopsy for controlling the 
disease [26]. 
Additionally, in pediatric patients with clinical suspicion of SS and a negative minor 
salivary gland biopsy result, a parotid gland biopsy could be safe and effective in 
order to establish histopathologic evidence for the diagnosis of SS [43]. 
Finally, it is noteworthy that the pain following labial and parotid biopsies is com-
parable in severity and disappears within 1 month [1]. 
Notwithstanding these aforementioned advantages, biopsies of the parotid gland 
have not become commonplace because of the concern for damage to the facial 
nerve, development of sialoceles and salivary fistulae (Table 2). In addition, pa-
rotid gland biopsies are not part of the established criteria for diagnosing SS and 
demand higher surgical expertise. They are validated for the AECG classification 
criteria, but not yet for the ACR classification criteria.
Comparison of sublingual gland biopsy to labial gland biopsy has shown that the 
sensitivity of sublingual gland biopsy is better than the one of the labial gland biop-
sy, while the specificity of the latter is better than that of the former (Table 3) [27]. 
As far as the post-operative complications are concerned, researchers claim that 
sublingual gland biopsy is a relatively safe procedure (Table 2). Owing the fact that 
placing a suture might increase the risk of ligaturing Wharton’s duct and lead to 
swelling of the floor of the mouth, no suture [28] or careful placement of one to two 
sutures could be an alternative [29]. A damage to the mental nerve is obviously not 
feasible, because of the operation site, while a damage to the lingual nerve related 
to this biopsy technique has never been reported in the litera ture. Advanced risk 
Figure 7: The technique of the biopsy of the parotid gland was slightly modified by the present 
authors with an incision below and slightly behind the earlobe.
in SS [33], develop as a result of hyperplasia of ductal basal cells within a lym-
phocytic infiltrate. In addition, well-formed lymphoid follicles or germinal centers, 
often adjacent to ductal epithelium, can be found in the major salivary glands [34]. 
Since both LELs and reactive lymphoid follicles are also indicative of malignant 
lymphoma, benign LELs must be discriminated from (pre)malignant lesions, using 
strict criteria [35,36]. 
Four to seven per cent of patients with SS develop malignant B cell lymphoma [37, 
38], 48%–75% of which are of the MALT-type. These B cell lymphomas are most 
frequently located in the parotid gland [39,40,41]. Assessment of SS patients who 
may have developed a MALT lymphoma is not always easy, but an incisional biopsy 
of the parotid gland can safely be performed under local anesthesia [4] and can 
help towards this diagnosis. Pollard and coworkers have established an algorithm 
Figure 6: Incisional biopsy of the parotid gland.
A. The area is anesthetized with local infiltra-
tion anesthesia. 
C. The skin is incised and the parotid capsule 
is exposed by blunt dissection. The capsule 
of the gland is carefully opened and a small 
amount of superficial parotid tissue is re-
moved. 
D. The procedure is completed with a 2 to 
3-layered closure with 4-0 gauge absorbable 
sutures (polyglycolic acid), while the skin lay-
er is closed with 5-0 nylon sutures. 
B. With a No 15 blade a small 1-2 cm incision is 
made just below and behind the earlobe near 
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Chapter 4
Treatment
